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 10 
Abstract: A number of clues point to a possible role of vitamin D in fighting COVID-19: a 
reduction in case growth speed with solar zenith angle, higher fatality rate in black people, lower 
fatality rate in populations that spend more time outdoors. Yet a direct demonstration that 
vitamin D deficiency is associated with COVID-19 fatalities has remained elusive. We show 
here in a comparison of 32 countries that countries with high prevalence of vitamin D deficiency 15 
among elderly females show a confirmed case fatality rate twice as high as those with low 
prevalence. We then show that this effect cannot be explained by differences in life expectancy 
between countries. A mechanistic role for vitamin D in the severity of COVID-19 is proposed. 
 
One Sentence Summary: Vitamin D deficiency among elderly females is associated with 20 
countrywide COVID-19 confirmed case fatality rates up to twice as high as those of countries 
with low vitamin D deficiency prevalence. 
 
Main Text:  
The world is in the grip of the COVID-19 pandemic. Public health measures that can reduce the 25 
risk of infection and death in addition to quarantines are desperately needed. 
The world is undergoing the largest public policy experiment ever conducted. Billions of people 
are being told to stay at home to avoid COVID-19 contagion. While isolation undoubtedly helps 
prevent contagion, having people stay at home and closing public parks has side effects that are 
not fully understood. UV radiation in natural sunlight stimulates vitamin D production in the 30 
hours and days following exposure1. At least a billion people worldwide are estimated to be 
vitamin D deficient, mainly because of inadequate exposure to sunlight and inadequate 
fortification of food with vitamin D2. Interventional and observational epidemiological studies 
provide evidence that vitamin D deficiency may confer increased risk of influenza and 
respiratory tract infection3,4. Vitamin D deficiency is also prevalent among patients infected with 35 
another RNA virus, HIV. Cell culture experiments support the thesis that vitamin D has direct 
anti-viral effects particularly against enveloped viruses. Though vitamin D's anti-viral 
mechanism has not been fully established, it may be linked to vitamin D's ability to up-regulate 
the anti-microbial peptides LL-37 and human beta defensin 25. Sunlight exposure improves 
survival in patients for some diseases6. The SARS coronavirus is inactivated under ultraviolet 40 
irradiation7. Viruses containing single-stranded nucleic acids such as coronaviruses are more 
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sensitive, unable to repair damage in the absence of a complementary strand. Vitamin D 
deficiency has been associated with increased risk of autoimmune diseases, infectious diseases 
and cardiovascular disease8. Studies from the Netherlands and France suggest that 
clots arise in 20–30% of critically ill COVID-19 patients9,10. Vitamin D has 
anticoagulant effects11,12. 5 
Are governments inadvertently putting populations at risk by locking them away from the 
sunlight for months at a time? Should public policy to slow the COVID-19 pandemic include 
both social isolation and sun exposure or vitamin D intake? 
Portugal, which borders Spain, has a COVID-19 mortality rate 75% lower than Spain. Norway 
and Denmark have low numbers of COVID-19 deaths, too, despite low winter sunlight levels. 10 
Addition of vitamin D to margarine is compulsory in Norway, Denmark, the Netherlands, 
Belgium and Portugal.  
COVID 19 is much more lethal to the elderly, and older populations tend to have much higher 
levels of vitamin D insufficiency13,14,15. 
43% of US COVID 19 deaths have occurred in nursing homes16. 84-93% of US nursing home 15 
patients have insufficient vitamin D levels17,18. 
Relevant amounts of vitamin D are found in seafood, egg yolk, butter and some mushrooms. 
Japan, a country with high fish consumption19, has been relatively spared, with less than 3% of 
the COVID 19 mortality of the US20.  
The synthesis of vitamin D in human skin is a two-stage process that begins with the production 20 
of previtamin D after irradiation of 7-dehydrocholesterol by ultraviolet (UV) radiation. A 
number of factors control the probability of a suitable UV photon reaching a molecule of 7-
dehydrocholesterol in the skin. These are astronomical factors that govern the solar zenith angle 
(SZA), and the local state of the atmosphere, determining the available solar UV radiation; skin 
pigmentation and age, determining competing absorbers of UV radiation and available 7-25 
dehydrocholesterol; individual behavior in the local surroundings, determining exposure of 
unprotected skin to available UV radiation. The only one of these influences that can be 
determined unequivocally for any situation is the SZA. At noon, SZA is at a minimum and is 
equal to latitude minus solar declination angle. At large SZAs there is insufficient solar UV 
radiation to initiate significant vitamin D synthesis21.  30 
One of us has previously shown SZA is the best predictor we know for COVID-19 case growth 
speed22. 
And yet, the topic remains controversial, and recent reviews maintain there is no evidence of a 
link between vitamin D and COVID-1923,24,25,26. 
To address this question, we compared the prevalence of severe vitamin D deficiency (25- 35 
hydroxyvitamin D serum concentration below 12 ng/ ml (30 nmol/l)) and intake levels in 
different countries27,28,29,30,31,32,33,34, with COVID-19 case growth rates and confirmed case 
fatality rates (cCFR).  
COVID-19 case growth speed was not significantly correlated with the prevalence of subclinical 
vitamin D deficiency in the female elderly population. This result is consistent with a recent 40 
study of the UK Biobank35. 
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A multiple linear regression model showed a significant correlation between both vitamin D 
deficiency in the female, but not male, elderly population and cCFR (Fig.1, p<0.05). The 
significant association with vitamin D deficiency prevalence is particularly notable given that the 
seasonality of vitamin D levels is likely to have introduced noise in the data. Furthermore, the 
fact that the effect is significant even with national averages, which mask the effect in 5 
individuals who are vitamin D deficient with others who are not, suggests the effect is likely 
much stronger when comparing individuals with different vitamin D levels. 
 
Figure 1. cCFR is significantly higher in countries with high prevalence of vitamin D deficiency 
among elderly females (p<0.05). 10 
 
Noticing that some of the countries with high cCFR yet low vitamin D deficiency, such as Brazil, 
had a large black population, and given our previous result showing COVID-19 mortality is 
higher in Black populations in low irradiance locations63, we carried out the same analysis 
correlating COVID-19 cCFR with the percentage of the population that is Black, and found a 15 
significant positive correlation (Fig. 2, p<0.05). 
To disambiguate the impact of each of these effects, we developed a multivariate linear model to 
estimate the significance of vitamin D deficiency prevalence and black population % when 
evaluated jointly. Both factors were significantly associated with COVID-19 cCFR (Table 1). 
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Figure 2. cCFR is significantly higher in countries with high percentage of black inhabitants 
(p<0.05). 
 
The prevalence of vitamin D deficiency among elderly females was not significantly correlated 5 
with the % of Blacks in the population.  
Vitamin D intake was not significantly correlated with case growth rate or with cCFR. 
The elderly are particularly susceptible to COVID-19. Even in low latitudes where severe 
vitamin D deficiency is rare, there is frequent occurrence of subclinical vitamin D deficiency, 
especially in elderly people36. 10 
Kumar and Srivastava recently claimed that average life expectancy could explain the apparent 
impact of vitamin D deficiency prevalence on COVID 1937. However, that study calculated 
cCFR with no lag between deaths and cases, which produces an inaccurate estimate of fatality. It 
also used a relatively small number of countries. We addressed both of those issues. We 
estimated confirmed case fatality rate as the average ratio between the number of new observed 15 
deaths each day and the number of new deaths that would have been expected given the number 
of new cases per day convolved by the diagnosis to death lag curve, as described in the 
literature38. A linear model incorporating all three factors showed vitamin D deficiency 
prevalence, but not life expectancy39 or percentage of the population black, were positively and 
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significantly correlated with COVID-19 cCFR (Table 2; p<0.05). Interestingly, we were able to 
replicate Kumar and Srivastava’s result when cCFR was measured the way they did, with 
constant zero lag between cases and deaths. Yet such an estimate fails to account for the 
significantly lower of cases that existed one lag before in an exponentially growing epidemic, 
and/or the number of cases yet to die. There was no significant correlation between each 5 
country’s cCFR and life expectancy, or between life expectancy and vitamin D deficiency 
prevalence. 
 
Table 1. Impact of vitamin D deficiency prevalence among elderly women and the percentage of 
the population that is Black on COVID-19 cCFR: 10 
 
                      Coefficient SE           p-Value   
                      ________    _________    __________ 
 
    (Intercept)       -3.3044       0.23164     3.2241e-13 15 
    % population Black:             10.585        4.4673      0.026205 
    Vitamin D deficiency:         0.010317     0.0047414       0.039629 
 
 
Number of observations: 27, Error degrees of freedom: 24 20 
Root Mean Squared Error: 0.645 
R-squared: 0.296,  Adjusted R-Squared: 0.237 
F-statistic vs. constant model: 5.04, p-value = 0.0148 
 
Table 2: Impact of the percentage of the population that is Black, vitamin D deficiency 25 
prevalence among elderly women and life expectancy on COVID-19 cCFR: 
Estimated Coefficients: 
Estimate         SE         tStat       pValue  
                      _________    ________    _______     ________ 
 30 
    (Intercept)         5.5474       6.6922     0.82895      0.41646 
    % population Black:             14.282       10.311      1.3851      0.18056 
    Vitamin D deficiency:         0.024229     0.010697       2.265     0.034217 
    Life expectancy:              -0.098322     0.083669     -1.1751       0.2531 
 35 
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Number of observations: 25, Error degrees of freedom: 21 
Root Mean Squared Error: 1.43 
R-squared: 0.27,  Adjusted R-Squared: 0.166 
F-statistic vs. constant model: 2.6, p-value = 0.0795 
Number of observations: 25, Error degrees of freedom: 21 5 
Root Mean Squared Error: 0.622 
R-squared: 0.295,  Adjusted R-Squared: 0.194 
F-statistic vs. constant model: 2.92, p-value = 0.0578 
 
Discussion: 10 
A retrospective cohort study of active and expired confirmed COVID-19 cases in Indonesia 
showed that when controlling for age, sex, and comorbidity, vitamin D status was strongly 
associated with COVID-19 mortality outcome of cases: vitamin D insufficiency showed an 
odds ratio (OR) for mortality of 7.63, and vitamin deficiency showed an OR of 10.1240. 
In a study performed at a single, tertiary care academic medical center in which the medical 15 
records of COVID-19 patients were retrospectively reviewed, the vitamin D insufficiency 
prevalence in ICU patients was 84.6%, vs. 57.1% in floor patients. Strikingly, 100% of ICU 
patients less than 75 years old had vitamin D insufficiency41.  
An analysis of global COVID-19 data using Causal Inference, constructing two contrasting 
models for vitamin D’s role in COVID-19 fatality, one causal and one acausal, setting out clearly 20 
multiple predictions made by each model, showed that observed data strongly matched 
predictions made by the causal model42. 
One in two fatal cases of COVID-19 experience a cytokine storm, 82% of whom are over the age 
of 6043. In older individuals, NLRP3 may be poised for hyperactivation by SARS-CoV-2 
components25. Elimination of severe vitamin D deficiency reduces the risk of high CRP levels 25 
(odds ratio of 2) which may be used as a surrogate marker of cytokine storm44. Vitamin D 
inhibits NLRP3 activation by impeding its deubiquitination mediated by BRCC345. Vitamin D 
downregulates NLRP3 and protects against toxin-induced cell death46 and modulates the NLRP3 
inflammasome activation47. In addition, likely due to its role in vasodilation and reducing 
inflammation, ACE2 partially protects against sepsis-induced- and SARS-induced severe acute 30 
lung injury in mice48. Vitamin D can increase the expressions of ACE2 mRNA and protein levels 
of ACE2 in rats49. Children have higher ACE expression than adults50, which could help explain 
their relative immunity to COVID-19. ACE2 expression is dramatically reduced with aging in 
rats of both genders: young-adult vs. old P < 0.001 (by 78% in male and 67% in female, 
respectively) and middle-aged vs. old P < 0.001 (by 71% in male rats and 59% in female rats, 35 
respectively). The decrease of ACE2 content is relatively slight between young-adult and 
middle-aged groups (by 25% in male and 18% in female, respectively). Although there is no 
gender-related difference of ACE2 in young-adult and middle-aged groups, a significantly higher 
ACE2 content was detected in old female rats than male. In conclusion, the more elevated ACE2 
in young adults as compared to aged groups may contribute to the predominance in SARS and 40 
COVID-19 attacks in aged populations51.  
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While men and women have the same COVID-19 prevalence, men with COVID-19 are more at 
risk for worse outcomes and death, independent of age52. Estrogen and testosterone impact 
immune system response and engagement, resulting in a less robust immunologic response in 
males and subsequent increased morbidity and mortality from viral respiratory illnesses53. 
Several animal models have demonstrated increased ACE2 activity in the male or 5 
ovariectomized model54.  
Males show an upregulation of angiotensin II receptor type 1 (AGTR1), a member of the renin-
angiotensin system (RAS) that plays a role in angiotensin-converting enzyme 2 (ACE2) activity 
modulation. In vivo studies have showed that ovariectomized females, in addition to males, 
usually have higher levels of ACE2 activity compared to non-ovariectomized females. This 10 
might indicate a possible role of the sex hormones in regulating ACE2 activity. Many reports 
highlight the role of human receptor ACE2, which also belongs to the renin-angiotensin system 
(RAS), in facilitating the binding of the SARS-CoV-2 to the host cells. While AGTR2 showed 
no significant difference in its expression between both genders, AGTR1 expression levels were 
higher in tissues obtained from male individuals compared to females55. 15 
Female gender is associated with lower vitamin D levels (14.5 ± 10.9 vs. 15.9 ± 9.5, p = 0.007) 
and independently associated with severe vitamin D deficiency (41.9% vs. 30.4%, p < 0.001; 
adjusted odds ratio (OR) (95% confidence interval (CI)) = 1.42 (1.08–1.87), p = 0.01). Yet note 
that a French and Canadian study reported elderly males suffered from a serious vitamin D 
deficiency as compared to elderly females56. 20 
Vitamin D and vitamin D receptor agonists modulate the immune system against over-reactivity 
towards tolerance; on this basis, vitamin D has been proposed as a therapeutic candidate to 
control autoimmune processes. Females retain greater immune reactivity and competence likely 
due to estrogens, which, at variance with androgens, are associated with a greater resilience to 
infections but also to a higher risk for autoimmunity57. Vitamin D deficiency is considered a risk 25 
factor for autoimmune diseases. Vitamin D and its analogues have been proposed as therapeutic 
tools in autoimmunity considering their exquisite immunoregulatory effect against over-
reactivity towards tolerance. Beneficial effects against autoimmune processes seem to be allowed 
by vitamin D acting in synergy with estrogens58.  
These facts may explain why it’s vitamin D deficiency among older females that is the stronger 30 
predictor of COVID-19 cCFR. 
DeGroot and Bontrop59 have pointed out that one of the prominent protein families that senses 
infection, and that is essential to the innate immune system, comprises the Toll-like receptors 
(TLR) (Akira and Takeda 2004): In humans, there are 10 different members, and each of them 
can be activated by different types of ligands stemming from disparate pathogens. TLR play a 35 
role in clearing infections. The TLR types present on intracellular membranes of endosomes 
(TLR3, 7, 8, and 9) are intended to register, though not exclusively, viral infections by detecting 
foreign types of nucleic acids (Fitzgerald and Kagan 2020). The nuclear material of 
coronaviruses is single-stranded RNA (ssRNA). The structurally related TLR7 and 8 tandem is 
encoded by the female X chromosome (Armant and Fenton 2002). Therefore, these latter two 40 
genes may represent gender-related risk factors. The prominent ligand for TLR7 and 8 is viral 
ssRNA (Diebold et al. 2004; Heil et al. 2004) and, more specifically for TLR8, its RNAse T2 
degradation products (Greulich et al. 2019). In humans, TLR7 is constitutively expressed on the 
membranes of endosomes in plasmacytoid dendritic cells (DC) and B lymphocytes, whereas 
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TLR8 is more prominently present in cells of the myeloid lineage such as monocytes and 
neutrophils (Hornung et al. 2002). TLR7-positive plamacytoid cells are copiously present in lung 
tissue (Plantinga et al. 2010). Upon activation of the TLR7 pathway, for instance by the 
influenza virus, plasmacytoid DC have the capacity to produce significant amounts of type I 
interferon (Di Domizio et al. 2009). Moreover, TLR8 is present in the lung, and is known to act 5 
upon infection by various viruses (Beignon et al. 2005; Heil et al. 2004). An immune response 
activated via the TLR7 and/ or 8 pathway may also induce unwanted side effects. SARS-Cov-1, 
for instance, may induce a cytokine storm (Tang et al. 2016), and the viral activation of 
neutrophils in the case of asthma may result in lung pathology (Li et al. 2013). One of the two 
female sex chromosomes is generally inactivated in females (Lyon 1992; Schurz et al. 2019). In 10 
female immune cells, however, TLR7 genes – and probably TLR8 – escape such silencing. As a 
consequence, the genetic information on both chromosomes is expressed, whereas male 
individuals possess only a single copy of the X chromosome (Souyris et al. 2018). Gender-
related expression profiles may result in a prominent dosage effect in which females are more 
prone to activate an immune response to single-stranded viruses such as SARS-CoV-2. 15 
Whilst males may be more vulnerable to the respiratory symptoms of COVID-19, women may 
be more likely to show the auto-immune like inflammatory response that appears to be 
modulated by vitamin D. 
Vitamin D deficiency and insufficiency occurs in 29.2% and 54.1% of black women, 
respectively, contrasting with 5% and 42.1% of white women60. 20 
A study of 660 women in South Los Angeles showed the prevalence of vitamin D deficiency 
among Hispanic women was 45% lower than among African American women61. One of us has 
previously shown that non-Black Hispanics have a significantly lower COVID-19 cCFR than 
non-Hispanics64. 
Any benefit of vitamin D needs to be balanced against the risk of toxicity, which is characterized 25 
by hypercalcemia. Daily brief, suberythemal exposure of a substantial area of the skin to 
ultraviolet light, climate allowing, provides adults with a safe, physiologic amount of vitamin D, 
equivalent to an oral intake of about 10,000 IU vitamin D3 per day, with the plasma 25-
hydroxyvitamin D (25(OH)D) concentration potentially reaching 220 nmol/L (88 ng/mL). The 
incremental consumption of 40 IU/d of vitamin D3 raises plasma 25(OH)D by about 1 nmol/L 30 
(0.4 ng/mL). High doses of vitamin D may cause hypercalcemia once the 25(OH)D 
concentration is well above the top of the physiologic range. Evidence from clinical trials shows, 
with a wide margin of confidence, that a prolonged intake of 10,000 IU/d of vitamin D3 poses no 
risk of adverse effects for adults, even if this is added to a rather high physiologic background 
level of vitamin D62. 35 
Inaction can be just as dangerous as action in the face of uncertainty. Several converging lines of 
evidence now suggest a role for sunlight in the prevention and treatment of COVID-19: sunnier 
places have slower COVID-19 growth22, African Americans and Black people in the UK have 
higher COVID-19 fatality rates in low irradiance locations63, US Latinos have higher sunlight 
exposure and lower COVID-19 fatality rates64, vitamin D-deficient populations such as the 40 
elderly and those in nursing homes have higher COVID-19 mortality rates, and vitamin D 
deficiency is associated with significantly higher COVID-19 fatality rates. 
Although the possibility remains that another variable correlated with vitamin D (such as 
sunlight or something correlated with sunlight) is behind the observed effects, we propose that 
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severe COVID-19 shows some characteristics of a virus-induced autoimmune disease, and that 
both sunlight and vitamin D be tested for its prevention and treatment.  
Whilst vitamin D supplementation has been causally linked in a randomized, double-blind, 
placebo controlled trial to the downregulation of interleukin-1 expression in peripheral blood 
mononuclear cells in humans65, and interleukin-1 Beta (IL-1β) is a critical component of lung 5 
inflammation during viral infection66, it should be noted that no significant correlation was found 
between vitamin D intake and COVID-19 fatality. Until a clinical trial of the impact of vitamin 
D supplementation on COVID-19 is complete, when sunlight is available, the safest course of 
action may be for populations vulnerable to COVID-19 may be to simply take a little daily dose 
of sunshine. 10 
 
Methods: 
Vitamin D levels are season-dependent. In Chile, for example, 20% of post-menopausal women 
have serum 25OHD concentrations below 15 ng/ml in summer, but 60% of them show that level 
of deficiency in winter. To address this issue, where possible, we used vitamin D deficiency 15 
during the season that the COVID-19 epidemic broke out in each country.  
COVID-19 case growth rates were assessed by computing the number of cases on the Nth day 
after the 100th case in each location. This method aligns by stage in the epidemic, is robust to 
later government interventions, and to idiosyncrasies about the first few cases in each location. 
cCFR were computed by dividing the number of COVID-19 deaths in each country on each day 20 
between the start of the COVID-19 pandemic and June 10th 2020 by the convolution of the 
number of cases in days 42 to 7 before and the distribution of lags between diagnoses and 
deaths67. 
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